Use of Anti-VEGF Agents and Lasers in Behçet’s Disease

Ocular form of Behçet’s Disease may end up in several complications. Anti-vasculoendothelial (anti-VEGF) agents and/or laser treatment are used in the management of these complications. Intravitreal Anti-VEGF agents are employed in Behçet’s Disease for the management of cystoid macular edema (CME) and neovascularization (NV). Bevacizumab is reported to be effective for CME in some studies, however there are also articles reporting that it does not provide significant anatomic or functional benefit. In Behçet’s Disease laser treatment is indispensable in the management of complications like secondary glaucoma, secondary cataract, retinal tears and retinal NV.